Abstract
The test-specific incidence of latent tuberculosis infection (LTBI) in healthcare workers from sub-Saharan Africa is unknown.
505 healthcare workers from South Africa were screened at baseline, and after 12 months, with a questionnaire, the tuberculin skin test (TST), and two T-cell assays (T-SPOT.TB and QuantiFERON-TB Gold-In-Tube). Test-specific conversion rates were calculated.
The prevalence of presumed LTBI at baseline was 84, 69 and 62% using the TST, QuantiFERON-TB Gold-In-Tube and T-SPOT.TB, respectively. The annual test-specific conversion rate, depending on the cut-off point used, was as follows: TST 38%; QuantiFERON-TB Gold-In-Tube 13–22%; and T-SPOT.TB 18–22%. Annual reversion rates were 4, 7 and 16%, respectively. The annual TST conversion rate was significantly higher than that derived from published local community-based data (IRR 3.53, 95% CI 1.81–6.88). Factors associated with conversion (any test) included healthcare sector of employment, counselling of tuberculosis patients, and a baseline positive TST (for T-SPOT.TB).
The annual rate of tuberculosis infection in South African healthcare workers was very high, irrespective of the testing method used, and may be explained by occupational exposure, as the rate was considerably higher than non-healthcare workers from the same community. Collectively, these data support the need for implementation of tuberculosis-specific infection control measures in Africa.
Abstract
South African healthcare workers have a high incidence of latent tuberculosis infection due to occupational exposure http://ow.ly/HDXhH
Introduction
Healthcare workers are considered a high-risk group for contracting occupational tuberculosis (TB) [1–4]. Based on limited data the median annual incidence of active TB among healthcare workers in TB endemic countries is approximately 1180/100 000 (interquartile range (IQR) 91–3222) [2]. An increasing incidence of active TB (both drug sensitive and resistant) in healthcare workers (and TB field researchers and community workers) has been demonstrated in tandem with a growing HIV epidemic in South Africa [5–9].
Retention of skilled healthcare workers in the public health system in these countries is crucial to the implementation of programmes that address the large TB and HIV burden [10]. This consideration has resulted in advocacy for more effective prevention, diagnosis, and management of TB and HIV in healthcare workers [11]. Implementation of infection control measures, allocation of resources, and rational planning of intervention strategies require accurate estimates of the scale of the problem. Moreover, the success of preventative strategies, such as targeted prophylaxis, needs to be measured through changes in the incidence of latent tuberculosis infection (LTBI) and disease progression. However, although the median annual risk of new LTBI in healthcare workers in high incidence countries is estimated to be 7.2% (IQR 4.1–14.3%), there are hardly any data from Africa to inform these estimates [12].
Traditionally, screening for LTBI was performed using the tuberculin skin test (TST). More recently, interferon-γ release assays (IGRAs) have been used for the diagnosis of LTBI. There are two commercially available IGRA assays: the T-SPOT.TB assay (Oxford Immunotech, Abingdon, UK) and the QuantiFERON-TB Gold-In-Tube (QFT-GIT) assay (Cellestis Ltd, Carnegie, Australia). These assays have some advantages over the TST, but also several drawbacks, such as the need for laboratory expertise and infrastructure and their relatively high cost [13]. They have been incorporated into testing guidelines in countries such as the USA and UK, where serial LTBI testing of healthcare workers is routinely performed [14, 15]. However, little research has focused on their potential value in healthcare workers from TB endemic countries. Moreover, annual rates of new TB infection in healthcare workers in Africa using different testing methods have hitherto not been determined.
To address these gaps in our knowledge we undertook a prospective study among healthcare workers in South Africa with the specific objectives of: 1) evaluating the prevalence of presumed LTBI using three different testing modalities (TST, T-SPOT.TB and QFT-GIT); 2) determining the incidence of LTBI as measured by test-specific conversion rates; and 3) determining the occupational factors associated with TB infection.
Methods
Study setting and participants
A prospective cohort study was conducted over a 2-year period (May 2009 to July 2011) among healthcare workers employed at seven healthcare facilities in Cape Town, South Africa. The five primary healthcare facilities in the sample are community-based and offer diagnostic and treatment services for TB, while the two secondary facilities are TB hospitals providing care to patients with complicated or drug-resistant TB. Staff were mainly employed by the provincial or local authority health departments, and the rest in the non-governmental sector. Recruitment took place sequentially over a year using a trained nurse to draw blood samples and administer the TST. Staff included both support (administrative, security and lay healthcare workers) and clinical staff (interns, researchers, trainees, nurses and doctors) over the age of 18 years. Those who were known to be pregnant or allergic to tuberculin were excluded from the study.
Participants completed an interviewer-administered questionnaire covering HIV status, and TB-associated and occupational and environmental risk factors. All underwent a digital chest radiograph, which was independently read by two physicians trained in the Chest Radiograph Review System (CRRS), a standardised epidemiological risk assessment tool for TB [16]. An expert chest radiologist resolved disagreement between the two readers. Those testing positive on symptom screen or chest radiograph were investigated further using sputum microscopy and culture in order to exclude active TB.
All participants were requested to have an HIV test, which was a rapid ELISA test performed in accordance with the manufacturer's instructions. A positive result was followed up with a confirmatory test using a rapid ELISA test from a different manufacturer, as per the study protocol. Participants were invited to report their HIV test result if previously tested. Refusal to disclose HIV status or undergo testing did not render participants ineligible for inclusion in the study.
The study was approved by the human research ethics committee of the Faculty of Health Sciences at the University of Cape Town, Cape Town, South Africa. All HIV infected individuals were referred for isoniazid prophylaxis and recommended for redeployment to a lower risk setting. Individuals newly diagnosed with active TB were referred for TB treatment.
TST testing and interpretation
The one step TST protocol was employed using two tuberculin units (0.1 mL) of RT23 Purified Protein Derivative (PPD; Staten Serum Institute, Copenhagen, Denmark), injected intradermally on the volar aspect of the forearm. The induration was measured by a trained reader after 48–72 h using the ballpoint reader method. An induration of ≥10 mm, or in the case of an HIV positive individual, ≥5 mm, was considered a positive test at baseline.
IGRA testing (QFT-GIT and T-SPOT.TB)
Bloods for the IGRA assays (QFT-GIT and the T-SPOT.TB, performed according to the manufacturers' instructions) were drawn concurrently or within 3 days of administering the TST to eliminate any effect of potential boosting [17].
TST conversion was considered to occur if the baseline TST was classified as negative (induration of <10 mm), and follow-up positive TST as positive (induration ≥10 mm with an increase of at least 10 mm) as per American Thoracic Society/Centers for Disease Control and Prevention and Infectious Diseases Society of America guidelines [18]. IGRA conversion was defined as a negative baseline test and a positive follow-up test. For QFT-GIT the required change was from a baseline interferon-γ <0.35 IU·mL−1 to a follow-up interferon-γ >0.35 IU·mL−1. For T-SPOT.TB a negative test at baseline changing to a positive test (≥6 spots increment in either panel A or B) on follow-up testing was required. Various cut-off points for conversion were explored for both IGRAs (table 1). Reversion was defined as a baseline positive test with a negative test at follow-up.
Interferon (IFN)-γ release assay conversion using different definitions
Statistical analysis
Statistical analyses were performed using Stata version 11 (Stata Corp, College Station, TX, USA). The prevalence of TB-associated risk factors and test outcomes were calculated at baseline. Agreement between test outcomes was computed using the Kappa statistic. Annual rates of TST and IGRA conversion and predictors of conversion were evaluated. Risk factors for test positivity were evaluated using odds ratios with 95% confidence intervals. Univariate logistic regression analysis was performed to evaluate the relationship between potential risk factors for TB infection and all three test outcomes. Separate multivariate regression models were then run for all variables of interest in relation to each test outcome, adjusting for covariates such as age and sex. A p-value of <0.05 was considered significant.
Results
Demographic characteristics and participation
In total 764 healthcare workers were eligible and 510 consented to be included in the study, representing a response rate of 67%. The follow-up phase of the study commenced 1 year after the baseline with 339 healthcare workers followed up from the original cohort of 505, representing a follow-up rate of 67%. The main reason for participants being lost to follow-up was leaving the facility (91 participants). Most had left for unknown reasons (68), three had resigned, three had retired and six were students who had completed their rotation, while another 11 had been transferred out (fig. 1).
Healthcare worker cohort screened at follow-up for latent tuberculosis infection. TST: tuberculin skin test. QFT-GIT: QuantiFERON-TB Gold-In-Tube.
All participants completed the questionnaire. HIV results were available for 329 participants and chest radiographs for 288 participants. A substantial proportion (56%) declined to have a repeat TST administered, so that only 142 participants had both a baseline and follow-up TST reading. Uptake of repeat IGRAs was very high with 99% of participants undergoing repeat testing. This resulted in 332 participants having valid paired results for QFT-GIT and 292 for T-SPOT.TB. The population predominantly consisted of females (71%) with 58% over the age of 40 years (table 2). Duration of employment in a healthcare environment was <10 years for the majority of participants (53%), while 30% reported a long duration of employment (>20 years; table 2).
Characteristics of participants who underwent repeat testing for latent tuberculosis infection by either tuberculin skin test and/or interferon-γ release assay
Occupational and environmental characteristics
Involvement in delivering healthcare services to TB patients ranged from 2% for bronchoscopy procedures to 49% for interviewing patients (table 3). High risk procedures, such as nursing of TB patients and collection of sputum samples, were performed by 30% and 22% of respondents, respectively. There was varying reported facility compliance with environmental control measures for TB infection control, with 64% of participants reporting that their facility had a specific infection control policy. Most displayed an awareness of ventilation measures being implemented at their facility (93%), while reported compliance with the provision of personal protective equipment was high (89–95%).
Prevalence of occupational and environmental risk factors among healthcare workers
Prevalence of TB associated risk factors and LTBI
The prevalence of reported BCG vaccination (in childhood) was high at 92% (table 4). Three participants who had previously been negative at baseline, had a positive HIV test at follow-up representing an HIV infection incidence of 1% (95% CI 0.18–2.56). Two new cases of active TB were diagnosed at follow-up and one participant not previously diagnosed had died of TB in the interval, yielding a TB incidence of nine per 1000 (1%, 95% CI 0.2–2.6). LTBI prevalence was high at 84% for TST, and 69% and 62% for QFT-GIT and T-SPOT.TB, respectively.
Prevalence of tuberculosis (TB)-associated risk factors at follow-up (unless otherwise indicated#)
Test agreement at baseline
There was only fair agreement between TST and QFT-GIT (concordance 72.1%; κ=0.29, 95% CI 0.19–0.39) and between TST and T-SPOT.TB (concordance 68.1%; κ=0.27, 95% CI 0.17–0.37). Agreement analysis was performed between the IGRA assays and three different cut-offs for TST (≥5, ≥10 and ≥15 mm) without taking HIV status into consideration and was essentially unchanged across the different cut-off points (table 5). There was substantial agreement between the two IGRAs (concordance 84%; κ=0.65, 95% CI 0.56–0.74).
Agreement and discordance between tuberculin skin test (TST) reactions and interferon-γ release assays (IGRAs) at baseline
TST and IGRA conversions and annual incidence of TB infection
The conversion rate represents the annual incidence of new TB infection as it measures new infections in those at risk after 1 year of observation. At follow-up testing, 13 out of 34 participants converted from a negative to a positive TST, representing an annual rate of infection of 38% (95% CI 22–56%), while 4% reverted from a previously positive to a negative test result.
For QFT-GIT, 25 out of 113 converted to a positive test, representing an annual rate of infection of 22% (95% CI 15–31%). The reversion rate was 7%. For T-SPOT.TB, owing to a higher yield of indeterminate results, only 292 participants test results were utilised to generate conversion and reversion estimates. Of those who tested negative at baseline, 25 out of 114 converted their test response to positive representing a conversion rate of 22% (95% CI 15–31%). The reversion rate for this IGRA assay at 16% was considerably higher than that demonstrated by TST (table 6).
Results of latent tuberculosis infection (LTBI) testing at baseline and follow-up including annualised rates of conversion
Subset analysis indicated no appreciable change in conversion or reversion rates for QFT-GIT (table 7). For T-SPOT.TB, however, there was a decline in conversion from 22% to 15% (p=0.31) and in the reversion rate from 16% to 14% (p=0.68) in the sample when compared to the rates demonstrated for the larger group. These differences were, however, not statistically significant.
Subset analysis of conversion rates in group of healthcare workers who had tuberculin skin test (TST), QuantiFERON-TB Gold-In-Tube (QFT-GIT) and T-SPOT.TB tests performed concurrently at follow-up
Different cut-off points were explored for IGRA conversion on account of the natural variability inherent in repeat use of these tests. For QFT-GIT, using the most stringent definition with a cut-off point of 0.70 IU·mL−1, the conversion rate declined to 13%, while for T-SPOT.TB, using an eight-spot increment, it declined to 18% (table 1).
Univariate and multivariate analysis of determinants of TST and IGRA conversion
Adjusted logistic regression models were applied to evaluate the relationship between each variable of interest and the conversion outcomes, treating age and sex as covariates (online data supplement).
In univariate analysis positive associations (OR ≥2) were shown for TST conversion in those participants with the following characteristics: age >40 years, exposure to environmental tobacco smoke, engaging in collection of sputum, TB symptom screen positive at follow-up and those who had a referral for HIV care and or TB investigations in the screening interval, but none of these associations were statistically significant in multivariate analysis.
Following multivariate analysis, the following associations remained significant. Individuals engaged in counselling TB patients were less likely to have a TST conversion (OR 0.12, 95% CI 0.15–0.92) while this same exposure variable emerged as a significant predictor of QFT-GIT conversion (OR 3.04, 95% CI 1.01–9.15).
Positive predictors of T-SPOT.TB conversion were healthcare sector employment, individuals in local authority employment were 14 times more likely to convert than those working for the provincial health department (OR 14.19, 95% CI 1.28–157.75), and having a positive TST at baseline (OR 3.40, 95% CI 1.02–11.34).
Discussion
This is the first prospective study to evaluate test-specific annual infection rates in healthcare workers in a TB endemic country. The key findings were that: 1) there was a high prevalence of presumed LTBI in healthcare workers irrespective of the test used (>60%); 2) annual rates of new infection (conversion rates) were exceptionally high irrespective of the testing method used (>20%); 3) the conversion rate was substantially higher than those derived from community-based survey data, suggesting that TB infection was most likely occupationally acquired; 4) the rate of infection was significantly higher than that reported in healthcare workers in other TB-endemic countries, e.g. India; 5) IGRAs were characterised by significant reversion rates over 1 year (7–16%); and 6) several occupational factors were identified that were significantly associated with test positivity.
The prevalence of LTBI based on TST was very high at 84% and similar to that of population-based studies of LTBI in South Africa using a TST value of ≥10 mm as cut-off [19, 20]. An LTBI prevalence of 88% has been demonstrated in adults (non-healthcare workers) 31–35 years of age in Cape Town [20]. In contrast, lower rates of TST positivity have been reported in healthcare workers in high and intermediate TB incidence countries such as India, Vietnam and Georgia (40–67%), using a TST cut-point of ≥10 mm [21–23]. Similarly, LTBI prevalence measured by QFT-GIT positivity (65%) was similar to that in the community (56%), and among healthcare workers in other high incidence countries (40–60%) [19, 21–24]. The high rates of LTBI and apparent lack of differential prevalence between community and healthcare workers in our settings most likely reflects the extremely high background incidence of TB, high rates of exposure in the work environment, a high prevalence of HIV co-infection increasing susceptibility, and the inclusion of non-governmental organisation staff which were, in the main, drawn from high TB prevalence communities.
The annual incidence of infection in this population was found to be extraordinarily high at between 20 and 38% depending on the assay used. While there are no comparable studies among South African adults, a recent study among adolescents in a high HIV prevalence community in Cape Town reported a high annual incidence of infection of 11% [25]. The authors argue that social contact is likely to be at its peak during adolescence and that risk of TB infection is more likely to resemble that of adults than children in the community. Using this estimate as an adult proxy measure, healthcare workers in our study were 3.5 times more likely to become infected during a 1-year period than a community-based comparison group. This is likely to reflect increased risk due to occupational exposure to TB. This annual risk was much higher (5–9 times) than demonstrated in two Indian healthcare worker-specific studies in a high TB incidence setting [1, 26].
IGRA-related conversion rates were lower than those using TST, but variable. The optimal cut-off point for conversion when using IGRAs for serial screening remains unclear, irrespective of the setting [27, 28]. The role of natural within subject variability, high reversion rates (7–16% with the IGRAs versus only 4% with TST), and a possible boosting effect on IGRAs by TST may explain part of this variability [29]. Recent published data using serial IGRAs in healthcare workers from the USA showed high rates of reversion in those that had apparently converted, thus calling into question how serial testing is currently performed and what cut-off points are used [30, 31]. More data are also needed to accurately define the “grey zone” around the cut-off point currently in use for QFT-GIT and T-SPOT.TB assays [17].
An increased risk of TST conversion in healthcare settings has been associated with occupational category, occupational setting and increasing age [32]. However, in our study there were no factors consistently associated with test conversion of either the TST or the IGRAs. The three-fold increased risk for QFT-GIT conversion associated with counselling of TB patients was the reverse of the negative association with TST conversion. This suggests that the test outcomes are not equivalent and calls into question the suggested substitution of TST with IGRAs in this population. The strong association between a baseline positive TST result and a later T-SPOT.TB conversion points to possible suboptimal sensitivity of the T-SPOT.TB. This association may also reflect marked variability of this assay, emphasising the need to re-examine cut-off points denoting conversion [17]. The strong association between T-SPOT.TB conversion (OR 14.19) and employment by the local authority is suggestive of a causative role for occupational exposure, as the provision of TB services is a function of local authority clinics and staff. The lack of a protective effect of occupational and environmental control measures on conversion rates may be ascribed to a reliance on reported rather than actual implementation of such measures or the failure to ensure the effectiveness of such interventions (e.g. failure to implement triage plans or maintenance of ultraviolet lights and ventilations systems). The lack of association between childhood BCG vaccination and TST positivity is consistent with the demonstrated lack of BCG effect on TST response when administered at birth [33].
There were several limitations to our study. This study was subject to volunteer selection bias at both the baseline and follow-up phase. Nurses and doctors at greater risk of TB infection were under-represented as a result of their limited time to participate in the study. The inclusion of HIV testing as part of the protocol may have discouraged participation due to stigma. Loss to follow up was a significant problem and probably led to attrition bias, the impact of which is unclear. In keeping with the healthy worker participation effect, retested participants were older, with longer length of service, and more likely to be HIV negative. Loss to follow up was also related to the mobility and high staff turnover in the non-governmental organisation sector. Since the study setting is one of the highest TB incidence areas in the country, the findings may not be generalisable to all healthcare workers in South Africa or to other high incidence occupational settings. The reliance on self-reported measures of occupational exposure also made it difficult to arrive at accurate measures of such exposure and its relationship with presumed LTBI.
In summary, this study demonstrates a very high prevalence of LTBI using different test modalities in healthcare workers in our setting. This very high annual incidence of infection is strongly suggestive of a causative role for occupational exposure. Nevertheless, the role and mechanisms of occupational exposure in driving TB infection among healthcare workers in TB endemic countries requires further exploration as effective infection control measures would have to be informed by a clear understanding of such factors.
ACKNOWLEDGEMENTS
Technical support: Vivienne Woodburne for laboratory support and processing of T-cell assays. Data collection: Elize Pietersen and Lameze Abrahams for conducting the fieldwork for the data collection (Lung Infection and Immunity Unit, Dept of Medicine, University of Cape Town, Cape Town, South Africa).
Footnotes
This article has supplementary material available from erj.ersjournals.com
Support statement: This study was funded by grants from the South African Medical Research Council, National Institute of Health (Fogarty International Clinical Research Fellowship (R24 TW007988-03) and SATBAT (IU2RTW007370-01A1)) and European Developing Clinical Trials Partnership (EDCTP TB NEAT: IP_09_32040_009). Funding information for this article has been deposited with FundRef. Kits and tubes for QuantiFERON®-TB Gold-In-Tube testing were sponsored by Cellestis, whilst T-SPOT.TB® Test kits were sponsored by Oxford Immunotech. Neither Cellestis, nor Oxford Immunotech had any role in the design and conduct of the study; collection, analysis or interpretation of data; and preparation, review or approval of the manuscript.
Conflict of interest: Disclosures can be found alongside the online version of this article at erj.ersjournals.com
- Received July 29, 2014.
- Accepted December 9, 2014.
- Copyright ©ERS 2015
References
